PF-AtlasКлинические испытания › NCT00023465

Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging

FDG-PET · Не указано

ID реестра
NCT00023465
Фаза
Не указано
Статус
Неизвестно
Препарат / вмешательство
FDG-PET
Спонсор
National Center for Research Resources (NCRR)
Набор участников
10
Центры
1

Об исследовании

It has been shown that neutrophils (a specific type of cell) are involved in inflammation in the lungs of CF patients. Neutrophil levels in CF patients have been measured by bronchoalveolar lavage (BAL), which samples cells in the fluid lining of the lungs. Other studies have measured neutrophil levels and inflammation in other parts of the body using PET scanning. This study aims to show that PET scanning can be used as a non-invasive marker of inflammation in the lungs of patients with CF, which would be a useful tool in treatment. The primary goal of this study is to draw a connection between the level of inflammation shown in the PET scan and the number of neutrophils obtained from the BAL. This study will also look at how the PET images relate to inflammatory molecules in the lungs and to the FEV-1 obtained through spirometry.

Открыть NCT00023465 на ClinicalTrials.gov →

Связанные материалы

Связанные исследования

Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT00023465 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.